PROTOCOL SUMMARY FOR PATIENTS

View Professional Summary

Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer


Basic Trial Information

Protocol Phase:Phase III
Study Category:Treatment
Current Protocol StatusActive
Age18 and over
Protocol SponsorNCI
Primary IDNCI-2011-01989
Other IDNCT01015833
Special Category

TRIAL DESCRIPTION

Purpose:
Eligibility:
Treatment Intervention:
Patient Disclaimer: